Influence
February 28, 2025

Predicting Alzheimer’s disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling

Kun Huang, PhD

Published in the Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. Here is a link to the article.

Regenstrief Institute authors: Kun Huang, PhD

This study addresses the challenge of identifying molecular mechanisms in living Alzheimer’s disease (AD) patients to support prognosis and precision medicine. Researchers applied an optimal transport-based method to transfer AD subtype labels from ROSMAP monocyte samples to peripheral blood mononuclear cell samples in the ADNI and ANMerge cohorts. Using graph-based transcriptomic mapping, differential expression, pathway analysis, diffusion pseudotime analysis, and survival analysis with real follow-up data, the study examined disease progression and potential prognostic biomarkers. The results confirmed accurate subtype label transfer and revealed that genes and pathways related to neutrophil degranulation, acute immune response, and IL-6 signaling are significantly associated with AD progression. The findings contribute to understanding AD heterogeneity and support the development of personalized treatment strategies.

Authors:
Xiaoqing Huang 1, Asha Jacob Jannu 2, Ziyan Song 1, Nur Jury-Garfe 3, Cristian A Lasagna-Reeves 3; Alzheimer’s Disease Neuroimaging Initiative; Travis S Johnson 1, Kun Huang 1, Jie Zhang 4
Affiliations

Affiliations

1Department of Biostatistics & Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA.

2Department of Biohealth Informatics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

3Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

4Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Related News

Group photo showing all Regenstrief-affiliated participants in the 2026 AMIA Annual Symposium in Dallas, TX

Regenstrief highlighted AI and learning health systems research at AMIA 2026

Regenstrief Institute research scientists and fellows shared work on artificial intelligence, health information exchange and public health informatics at

photo of Dr. Josh Vest with New England Journal of Medicine logo

NEJM Perspective calls for screening tailored to older adults’ social needs

Regenstrief Institute and Weill Cornell Medicine researchers outline how health systems can identify unmet needs more accurately and connect

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight